BPC-157 101
What Is BPC-157?
BPC-157 is a synthetic peptide composed of a 15-amino-acid sequence, originally derived from a partial sequence found in human gastric juice. Since its identification, it has become a widely referenced compound within the peptide research community, studied primarily in laboratory and preclinical settings rather than as an approved pharmaceutical.
BPC-157 is not FDA-approved for any human therapeutic use. It is classified and sold as a research compound, intended strictly for laboratory and analytical purposes.
Peptide Classification
As a synthetic peptide, BPC-157 is manufactured through solid-phase peptide synthesis, a standard laboratory production method used to build peptide chains with defined amino acid sequences. This is the same general manufacturing approach used across the broader research peptide industry.
What Researchers Look For in Peptide Sourcing
Peptide compounds are especially sensitive to manufacturing quality, since synthesis errors or poor purification can introduce impurities that are difficult to detect without lab verification. Key sourcing criteria include:
- Sequence accuracy — confirmation that the synthesized peptide matches the intended amino acid sequence
- Purity percentage — verified via independent laboratory testing, not manufacturer self-reporting
- Stability and storage documentation — peptides are sensitive to temperature and handling conditions
How Our BPC-157 Is Made
Our BPC-157 is manufactured in a GMP-certified facility and independently tested by a third-party lab, with a Certificate of Analysis (COA) provided for the specific batch supplied.
Format
BPC-157 is available in 1000mcg capsule form, providing consistent, pre-measured units for laboratory handling.
Important Notice
All Bendazole Lab products are sold strictly for laboratory, analytical, and educational research purposes. They are not intended for human or animal consumption and are not intended to diagnose, treat, cure, or prevent any disease.